Skip to main content
Top

29-01-2025 | Malnutrition

Global prevalence and moderating factors of malnutrition in colorectal cancer survivors: A meta-analysis

Authors: Hidayat Arifin, Yu-Hao Chu, Ruey Chen, Chiu-Kuei Lee, Doresses Liu, Christina Yeni Kustanti, Tintin Sukartini, Kondwani Joseph Banda, Kuei-Ru Chou

Published in: Journal of Cancer Survivorship

Login to get access

Abstract

Purpose

This meta-analysis aims to estimate the global prevalence of severe, moderate, overall malnutrition and moderating factors of malnutrition in colorectal cancer (CRC) survivors.

Methods

A comprehensive search was conducted in Embase, CINAHL, Medline-OVID, PubMed, Scopus, and Web of Science from inception to February 8, 2024, without language, region, or publication date restrictions. A generalized linear mixed model and random-effects model were used to examine the pooled prevalence, and moderator analyses were implemented to investigate variations in the pooled prevalence.

Results

In 35 studies involving 9,278 colorectal cancer survivors, the global prevalence was 12.10% for severe malnutrition (95% confidence interval (CI): 7.28–16.92; n = 507), 33.13% for moderate malnutrition (95% CI: 28.93–37.34; n: 2,192), and 47.78% for overall malnutrition (95% CI: 41.60–53.96; n: 3,812). Asia showed higher rates of severe malnutrition 16.67% (95% CI: 4.66–28.68, n: 232) and overall malnutrition 53.17% (95% CI: 39.66–66.69, n: 1,913), whereas low-middle income countries demonstrated higher rates of overall malnutrition 67.46% (95% CI: 30.25–100.00, n: 82). Male sex, colon cancer, advanced stage, metastasis, chemotherapy, surgery, adjuvant treatment, smoking, alcohol consumption, hypertension, and diabetes significantly moderated overall malnutrition prevalence.

Conclusions

This meta-analysis reports detailed data on the global prevalence of CRC survivors experience malnutrition, highlighting that health-care professionals should consider the identified moderating factors.

Implications for cancer survivors

Addressing malnutrition in CRC survivors is critical, as early and proactive nutritional management can enhance recovery, improve quality of life, and potentially reduce cancer-related complications associated with malnutrition. 
Appendix
Available only for authorised users
Literature
2.
go back to reference Lewandowska A, Religioni U, Czerw A, Deptała A, Karakiewicz B, Partyka O, et al. Nutritional Treatment of Patients with Colorectal Cancer. Int J Environ Res Public Health. 2022;19:1–12.CrossRef Lewandowska A, Religioni U, Czerw A, Deptała A, Karakiewicz B, Partyka O, et al. Nutritional Treatment of Patients with Colorectal Cancer. Int J Environ Res Public Health. 2022;19:1–12.CrossRef
3.
go back to reference Vitaloni M, Caccialanza R, Ravasco P, Carrato A, Kapala A, de van der Schueren M, et al. The impact of nutrition on the lives of patients with digestive cancers: a position paper. Support Care Cancer. 2022;30:7991–6. Vitaloni M, Caccialanza R, Ravasco P, Carrato A, Kapala A, de van der Schueren M, et al. The impact of nutrition on the lives of patients with digestive cancers: a position paper. Support Care Cancer. 2022;30:7991–6.
4.
go back to reference Arends J. Malnutrition in cancer patients: Causes, consequences and treatment options. Eur J Surg Oncol. 2023;50:1–9. Arends J. Malnutrition in cancer patients: Causes, consequences and treatment options. Eur J Surg Oncol. 2023;50:1–9.
5.
go back to reference Gebremedhin TK, Cherie A, Tolera BD, Atinafu BT, Demelew TM. Prevalence and risk factors of malnutrition among adult cancer patients receiving chemotherapy treatment in cancer center, Ethiopia: cross-sectional study. Heliyon. 2021;7: e07362.PubMedPubMedCentralCrossRef Gebremedhin TK, Cherie A, Tolera BD, Atinafu BT, Demelew TM. Prevalence and risk factors of malnutrition among adult cancer patients receiving chemotherapy treatment in cancer center, Ethiopia: cross-sectional study. Heliyon. 2021;7: e07362.PubMedPubMedCentralCrossRef
6.
go back to reference Ma L, Poulin P, Feldstain A, Chasen MR. The association between malnutrition and psychological distress in patients with advanced head-and-neck cancer. Curr Oncol. 2013;20:e554–60.PubMedPubMedCentralCrossRef Ma L, Poulin P, Feldstain A, Chasen MR. The association between malnutrition and psychological distress in patients with advanced head-and-neck cancer. Curr Oncol. 2013;20:e554–60.PubMedPubMedCentralCrossRef
7.
go back to reference Hiatt RA, Clayton MF, Collins KK, Gold HT, Laiyemo AO, Truesdale KP, Ritzwoller DP. The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes. J Natl Cancer Inst. 2023;115:886–95.PubMedPubMedCentralCrossRef Hiatt RA, Clayton MF, Collins KK, Gold HT, Laiyemo AO, Truesdale KP, Ritzwoller DP. The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes. J Natl Cancer Inst. 2023;115:886–95.PubMedPubMedCentralCrossRef
8.
go back to reference Hu W-H, Cajas-Monson LC, Eisenstein S, Parry L, Cosman B, Ramamoorthy S. Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: an analysis of ACS-NSQIP. Nutr J. 2015;14:91.PubMedPubMedCentralCrossRef Hu W-H, Cajas-Monson LC, Eisenstein S, Parry L, Cosman B, Ramamoorthy S. Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: an analysis of ACS-NSQIP. Nutr J. 2015;14:91.PubMedPubMedCentralCrossRef
9.
go back to reference Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996;12:S15–9.PubMedCrossRef Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996;12:S15–9.PubMedCrossRef
10.
go back to reference Detsky AS, JR M, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy K. What is subjective global assessment of nutritional status? Journal of parenteral and enteral nutrition. 1987;11:8–13. Detsky AS, JR M, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy K. What is subjective global assessment of nutritional status? Journal of parenteral and enteral nutrition. 1987;11:8–13.
13.
go back to reference Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer. J Parenter Enter Nutr. 2014;38:196–204.CrossRef Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer. J Parenter Enter Nutr. 2014;38:196–204.CrossRef
14.
go back to reference Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.PubMedCrossRef Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.PubMedCrossRef
15.
go back to reference Klek S, Szybinski P, Szczepanek K. Perioperative immunonutrition in surgical cancer patients: a summary of a decade of research. World J Surg. 2014;38:803–12.PubMedCrossRef Klek S, Szybinski P, Szczepanek K. Perioperative immunonutrition in surgical cancer patients: a summary of a decade of research. World J Surg. 2014;38:803–12.PubMedCrossRef
16.
go back to reference Hiramatsu K, Shindoh J, Hanaoka Y, Toda S, Ueno M, Matoba S, Kuroyanagi H. Postoperative Nutritional Status is Predictive of the Survival Outcomes in Patients Undergoing Resection of Stage III Colorectal Cancer. World J Surg. 2021;45:3198–205.PubMedCrossRef Hiramatsu K, Shindoh J, Hanaoka Y, Toda S, Ueno M, Matoba S, Kuroyanagi H. Postoperative Nutritional Status is Predictive of the Survival Outcomes in Patients Undergoing Resection of Stage III Colorectal Cancer. World J Surg. 2021;45:3198–205.PubMedCrossRef
17.
go back to reference Arifin H, Chen R, Banda KJ, Kustanti CY, Chang C-Y, Lin H-C, et al. Meta-analysis and moderator analysis of the prevalence of malnutrition and malnutrition risk among older adults with dementia. Int J Nurs Stud. 2024;150: 104648.PubMedCrossRef Arifin H, Chen R, Banda KJ, Kustanti CY, Chang C-Y, Lin H-C, et al. Meta-analysis and moderator analysis of the prevalence of malnutrition and malnutrition risk among older adults with dementia. Int J Nurs Stud. 2024;150: 104648.PubMedCrossRef
18.
go back to reference Zang Y, Xu W, Qiu Y, Gong D, Fan Y. Association between Risk of Malnutrition Defined by the Nutritional Risk Screening 2002 and Postoperative Complications and Overall Survival in Patients with Cancer: A Meta-Analysis. Nutr Cancer. 2023;75:1600–9.PubMedCrossRef Zang Y, Xu W, Qiu Y, Gong D, Fan Y. Association between Risk of Malnutrition Defined by the Nutritional Risk Screening 2002 and Postoperative Complications and Overall Survival in Patients with Cancer: A Meta-Analysis. Nutr Cancer. 2023;75:1600–9.PubMedCrossRef
19.
go back to reference Bian W, Li Y, Wang Y, Chang L, Deng L, Li Y, et al. Prevalence of malnutrition based on global leadership initiative in malnutrition criteria for completeness of diagnosis and future risk of malnutrition based on current malnutrition diagnosis: systematic review and meta-analysis. Frontiers in Nutrition. 2023;10. Bian W, Li Y, Wang Y, Chang L, Deng L, Li Y, et al. Prevalence of malnutrition based on global leadership initiative in malnutrition criteria for completeness of diagnosis and future risk of malnutrition based on current malnutrition diagnosis: systematic review and meta-analysis. Frontiers in Nutrition. 2023;10.
20.
go back to reference Yin L, Chong F, Huo Z, Li N, Liu J, Xu H. GLIM-defined malnutrition and overall survival in cancer patients: A meta-analysis. J Parenter Enteral Nutr. 2023;47:207–19.CrossRef Yin L, Chong F, Huo Z, Li N, Liu J, Xu H. GLIM-defined malnutrition and overall survival in cancer patients: A meta-analysis. J Parenter Enteral Nutr. 2023;47:207–19.CrossRef
21.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting. JAMA. 2000;283:2008–12.PubMedCrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting. JAMA. 2000;283:2008–12.PubMedCrossRef
22.
go back to reference Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, PRISMA, et al. explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2020;2021:372. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, PRISMA, et al. explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2020;2021:372.
24.
go back to reference Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment. Curr Opin Clin Nutr Metab Care. 2017;20:322–9.PubMedCrossRef Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment. Curr Opin Clin Nutr Metab Care. 2017;20:322–9.PubMedCrossRef
25.
go back to reference Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF. Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr. 2005;59:35–40.PubMedCrossRef Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF. Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr. 2005;59:35–40.PubMedCrossRef
26.
go back to reference Duerksen DR, Laporte M, Jeejeebhoy K. Evaluation of Nutrition Status Using the Subjective Global Assessment: Malnutrition, Cachexia, and Sarcopenia. Nutr Clin Pract. 2021;36:942–56.PubMedCrossRef Duerksen DR, Laporte M, Jeejeebhoy K. Evaluation of Nutrition Status Using the Subjective Global Assessment: Malnutrition, Cachexia, and Sarcopenia. Nutr Clin Pract. 2021;36:942–56.PubMedCrossRef
27.
go back to reference Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934–9.PubMedCrossRef Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934–9.PubMedCrossRef
28.
go back to reference Lundorff M, Holmgren H, Zachariae R, Farver-Vestergaard I, O’Connor M. Prevalence of prolonged grief disorder in adult bereavement: A systematic review and meta-analysis. J Affect Disord. 2017;212:138–49.PubMedCrossRef Lundorff M, Holmgren H, Zachariae R, Farver-Vestergaard I, O’Connor M. Prevalence of prolonged grief disorder in adult bereavement: A systematic review and meta-analysis. J Affect Disord. 2017;212:138–49.PubMedCrossRef
29.
go back to reference Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97–111.PubMedCrossRef Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97–111.PubMedCrossRef
30.
go back to reference Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions: John Wiley & Sons; 2019. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions: John Wiley & Sons; 2019.
31.
go back to reference Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676–80.PubMedCrossRef Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676–80.PubMedCrossRef
32.
go back to reference Kossmeier M, Tran US, Voracek M. Visual Inference for the Funnel Plot in Meta-Analysis. Zeitschrift für Psychologie. 2019;227:83–9.CrossRef Kossmeier M, Tran US, Voracek M. Visual Inference for the Funnel Plot in Meta-Analysis. Zeitschrift für Psychologie. 2019;227:83–9.CrossRef
33.
go back to reference Shi L, Lin L. The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine (Baltimore). 2019;98: e15987.PubMedCrossRef Shi L, Lin L. The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine (Baltimore). 2019;98: e15987.PubMedCrossRef
34.
go back to reference Abe Vicente M, Barão K, Silva TD, Forones NM. What are the most effective methods for assessment of nutritional status in outpatients with gastric and colorectal cancer? Nutr Hosp. 2013;28:585–91.PubMed Abe Vicente M, Barão K, Silva TD, Forones NM. What are the most effective methods for assessment of nutritional status in outpatients with gastric and colorectal cancer? Nutr Hosp. 2013;28:585–91.PubMed
35.
go back to reference Alkan ŞB, Artaç M, Rakıcıoğlu N. The relationship between nutritional status and handgrip strength in adult cancer patients: a cross-sectional study. Support Care Cancer. 2018;26:2441–51.PubMedCrossRef Alkan ŞB, Artaç M, Rakıcıoğlu N. The relationship between nutritional status and handgrip strength in adult cancer patients: a cross-sectional study. Support Care Cancer. 2018;26:2441–51.PubMedCrossRef
36.
go back to reference Barao K, Abe Vicente Cavagnari M, Silva Fucuta P, Manoukian Forones N. Association between Nutrition Status and Survival in Elderly Patients with Colorectal Cancer. Nutrition in Clinical Practice. 2017;32:658–63. Barao K, Abe Vicente Cavagnari M, Silva Fucuta P, Manoukian Forones N. Association between Nutrition Status and Survival in Elderly Patients with Colorectal Cancer. Nutrition in Clinical Practice. 2017;32:658–63.
37.
go back to reference Barbosa LR, Lacerda-Filho A, Barbosa LC. Immediate preoperative nutritional status of patients with colorectal cancer: a warning. Arq Gastroenterol. 2014;51:331–6.PubMedCrossRef Barbosa LR, Lacerda-Filho A, Barbosa LC. Immediate preoperative nutritional status of patients with colorectal cancer: a warning. Arq Gastroenterol. 2014;51:331–6.PubMedCrossRef
38.
go back to reference Beaton J, Carey S, Solomon M, Young J. Preoperative and postoperative nutritional status of patients following pelvic exenteration surgery for rectal cancer. e-SPEN Journal. 2013;8:e164-e8. Beaton J, Carey S, Solomon M, Young J. Preoperative and postoperative nutritional status of patients following pelvic exenteration surgery for rectal cancer. e-SPEN Journal. 2013;8:e164-e8.
39.
go back to reference Campos SBG, de Azevedo SCL, Gomes T, Bueno NB, Goulart MOF, Moura FA. Lack of Concordance among Nutritional Diagnostic Methods in Newly Diagnosed Colorectal Cancer Patients. Nutr Cancer. 2022;74:2067–74.PubMedCrossRef Campos SBG, de Azevedo SCL, Gomes T, Bueno NB, Goulart MOF, Moura FA. Lack of Concordance among Nutritional Diagnostic Methods in Newly Diagnosed Colorectal Cancer Patients. Nutr Cancer. 2022;74:2067–74.PubMedCrossRef
40.
go back to reference Cavagnari MAV, Silva TD, Pereira MAH, Sauer LJ, Shigueoka D, Saad SS, et al. Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer. BMC Cancer. 2019;19. Cavagnari MAV, Silva TD, Pereira MAH, Sauer LJ, Shigueoka D, Saad SS, et al. Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer. BMC Cancer. 2019;19.
41.
go back to reference Cavagnari MAV, Vidigal VM, Silva TD, Barão K, Forones NM. Adiponectin, vitamin d and nutritional status in patients with advanced colorectal cancer or during follow-up. Arq Gastroenterol. 2019;56:172–7.PubMedCrossRef Cavagnari MAV, Vidigal VM, Silva TD, Barão K, Forones NM. Adiponectin, vitamin d and nutritional status in patients with advanced colorectal cancer or during follow-up. Arq Gastroenterol. 2019;56:172–7.PubMedCrossRef
42.
go back to reference da Silva CA, Gonzalez MC, Martucci RB, Feijó PM, Rodrigues VD, de Pinho NB, Souza NC. Predictive validity of GLIM malnutrition diagnosis in patients with colorectal cancer. J Parenter Enter Nutr. 2023;47:420–8.CrossRef da Silva CA, Gonzalez MC, Martucci RB, Feijó PM, Rodrigues VD, de Pinho NB, Souza NC. Predictive validity of GLIM malnutrition diagnosis in patients with colorectal cancer. J Parenter Enter Nutr. 2023;47:420–8.CrossRef
43.
go back to reference de Sousa IM, Silva FM, de Carvalho ALM, da Rocha IMG, Fayh APT. Accuracy of isolated nutrition indicators in diagnosing malnutrition and their prognostic value to predict death in patients with gastric and colorectal cancer: A prospective study. J Parenter Enter Nutr. 2022;46:508–16.CrossRef de Sousa IM, Silva FM, de Carvalho ALM, da Rocha IMG, Fayh APT. Accuracy of isolated nutrition indicators in diagnosing malnutrition and their prognostic value to predict death in patients with gastric and colorectal cancer: A prospective study. J Parenter Enter Nutr. 2022;46:508–16.CrossRef
44.
go back to reference Djordjevic A, Deftereos I, Carter VM, Morris S, Shannon R, Kiss N, Yeung JMC. Ability of malnutrition screening and assessment tools to identify computed tomography defined low muscle mass in colorectal cancer surgery. Nutr Clin Pract. 2022;37:666–76.PubMedCrossRef Djordjevic A, Deftereos I, Carter VM, Morris S, Shannon R, Kiss N, Yeung JMC. Ability of malnutrition screening and assessment tools to identify computed tomography defined low muscle mass in colorectal cancer surgery. Nutr Clin Pract. 2022;37:666–76.PubMedCrossRef
45.
go back to reference Faramarzi E, Mahdavi R, Mohammad-Zadeh M, Nasirimotlagh B. Validation of nutritional risk index method against patient-generated subjective global assessment in screening malnutrition in colorectal cancer patients. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu. 2013;25:544–8. Faramarzi E, Mahdavi R, Mohammad-Zadeh M, Nasirimotlagh B. Validation of nutritional risk index method against patient-generated subjective global assessment in screening malnutrition in colorectal cancer patients. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu. 2013;25:544–8.
46.
go back to reference Gillis C, Richer L, Fenton TR, Gramlich L, Keller H, Culos-Reed SN, et al. Colorectal cancer patients with malnutrition suffer poor physical and mental health before surgery. Surgery. 2021;170:841–7.PubMedCrossRef Gillis C, Richer L, Fenton TR, Gramlich L, Keller H, Culos-Reed SN, et al. Colorectal cancer patients with malnutrition suffer poor physical and mental health before surgery. Surgery. 2021;170:841–7.PubMedCrossRef
47.
go back to reference Gonsalves AR, Ambrogini O, Forones NM. Noninvasive breath tests for diagnosis of sibo and lactose intolerance in patients on chemotherapy treatment for colorectal and gastric cancer. Arq Gastroenterol. 2021;58:26–31.CrossRef Gonsalves AR, Ambrogini O, Forones NM. Noninvasive breath tests for diagnosis of sibo and lactose intolerance in patients on chemotherapy treatment for colorectal and gastric cancer. Arq Gastroenterol. 2021;58:26–31.CrossRef
48.
go back to reference Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA. Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol. 2006;59:704–9.PubMedCrossRef Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA. Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol. 2006;59:704–9.PubMedCrossRef
49.
go back to reference Heredia M, Canales S, Sáez C, Testillano M. The nutritional status of patients with colorectal cancer undergoing chemotherapy. Farmacia Hospitalaria (1130–6343). 2008;32:35–7. Heredia M, Canales S, Sáez C, Testillano M. The nutritional status of patients with colorectal cancer undergoing chemotherapy. Farmacia Hospitalaria (1130–6343). 2008;32:35–7.
50.
go back to reference Karin M, Bogut A, Hojsak I, Babić E, Volarić M, Bevanda M. Nutritional status and its effect on complications in patients with colorectal cancer. Wien Klin Wochenschr. 2020;132:431–7.PubMedCrossRef Karin M, Bogut A, Hojsak I, Babić E, Volarić M, Bevanda M. Nutritional status and its effect on complications in patients with colorectal cancer. Wien Klin Wochenschr. 2020;132:431–7.PubMedCrossRef
51.
go back to reference Lohsiriwat V. The influence of preoperative nutritional status on the outcomes of an enhanced recovery after surgery (ERAS) programme for colorectal cancer surgery. Tech Coloproctol. 2014;18:1075–80.PubMedCrossRef Lohsiriwat V. The influence of preoperative nutritional status on the outcomes of an enhanced recovery after surgery (ERAS) programme for colorectal cancer surgery. Tech Coloproctol. 2014;18:1075–80.PubMedCrossRef
52.
go back to reference Mauricio SF, Xiao J, Prado CM, Gonzalez MC, Correia MITD. Different nutritional assessment tools as predictors of postoperative complications in patients undergoing colorectal cancer resection. Clinical nutrition (Edinburgh, Scotland). 2018;37:1505–11.PubMedCrossRef Mauricio SF, Xiao J, Prado CM, Gonzalez MC, Correia MITD. Different nutritional assessment tools as predictors of postoperative complications in patients undergoing colorectal cancer resection. Clinical nutrition (Edinburgh, Scotland). 2018;37:1505–11.PubMedCrossRef
53.
go back to reference Meissner C, Tiegges S, Broehl M, Otto R, Ridwelski K. International study on the prevalence of malnutrition in centralized care for colorectal cancer patients. Innovative surgical sciences. 2023;8:83–92.PubMedPubMedCentralCrossRef Meissner C, Tiegges S, Broehl M, Otto R, Ridwelski K. International study on the prevalence of malnutrition in centralized care for colorectal cancer patients. Innovative surgical sciences. 2023;8:83–92.PubMedPubMedCentralCrossRef
54.
go back to reference Read JA, Choy STB, Beale P, Clarke SJ. An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic. Asia Pac J Clin Oncol. 2006;2:80–6.CrossRef Read JA, Choy STB, Beale P, Clarke SJ. An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic. Asia Pac J Clin Oncol. 2006;2:80–6.CrossRef
55.
go back to reference Ruan XL, Wang XA, Zhang Q, Nakyeyune R, Shao Y, Shen Y, et al. The performance of three nutritional tools varied in colorectal cancer patients: a retrospective analysis. J Clin Epidemiol. 2022;149:12–22.PubMedCrossRef Ruan XL, Wang XA, Zhang Q, Nakyeyune R, Shao Y, Shen Y, et al. The performance of three nutritional tools varied in colorectal cancer patients: a retrospective analysis. J Clin Epidemiol. 2022;149:12–22.PubMedCrossRef
56.
go back to reference Shim H, Cheong JH, Lee KY, Lee H, Lee JG, Noh SH. Perioperative nutritional status changes in gastrointestinal cancer patients. Yonsei Med J. 2013;54:1370–6.PubMedPubMedCentralCrossRef Shim H, Cheong JH, Lee KY, Lee H, Lee JG, Noh SH. Perioperative nutritional status changes in gastrointestinal cancer patients. Yonsei Med J. 2013;54:1370–6.PubMedPubMedCentralCrossRef
57.
go back to reference Silva TH, Peres WAF, Rosa KSdC, Schilithz AOC, de Oliveira LC, Murad LB. Advanced Stage of Disease and Systemic Inflammation as Factors Associated With Referral of Patients With Colorectal Cancer to a Palliative Care Unit. American Journal of Hospice and Palliative Medicine®. 2020;37:859–65. Silva TH, Peres WAF, Rosa KSdC, Schilithz AOC, de Oliveira LC, Murad LB. Advanced Stage of Disease and Systemic Inflammation as Factors Associated With Referral of Patients With Colorectal Cancer to a Palliative Care Unit. American Journal of Hospice and Palliative Medicine®. 2020;37:859–65.
58.
go back to reference Souza NC, Gonzalez MC, Martucci RB, Rodrigues VD, de Pinho NB, Qureshi AR, Avesani CM. Comparative Analysis Between Computed Tomography and Surrogate Methods to Detect Low Muscle Mass Among Colorectal Cancer Patients. J Parenter Enter Nutr. 2020;44:1328–37.CrossRef Souza NC, Gonzalez MC, Martucci RB, Rodrigues VD, de Pinho NB, Qureshi AR, Avesani CM. Comparative Analysis Between Computed Tomography and Surrogate Methods to Detect Low Muscle Mass Among Colorectal Cancer Patients. J Parenter Enter Nutr. 2020;44:1328–37.CrossRef
59.
go back to reference Vashi PG, Gorsuch K, Wan L, Hill D, Block C, Gupta D. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer. PLOS ONE. 2019;14. Vashi PG, Gorsuch K, Wan L, Hill D, Block C, Gupta D. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer. PLOS ONE. 2019;14.
60.
go back to reference Wang WJ, Li TT, Wang X, Li W, Cui JW. Combining the Patient-Generated Subjective Global Assessment (PG-SGA) and Objective Nutrition Assessment Parameters Better Predicts Malnutrition in Elderly Patients with Colorectal Cancer. Journal of Nutritional Oncology. 2020;5. Wang WJ, Li TT, Wang X, Li W, Cui JW. Combining the Patient-Generated Subjective Global Assessment (PG-SGA) and Objective Nutrition Assessment Parameters Better Predicts Malnutrition in Elderly Patients with Colorectal Cancer. Journal of Nutritional Oncology. 2020;5.
61.
go back to reference Zaid ZA, Jackson K, Cobiac L, Kandiah M. Relationship between Quality of Life and Nutritional Status in Colorectal Cancer Patients Undergoing Chemotherapy. Malaysian Journal of Nutrition. 2017;23. Zaid ZA, Jackson K, Cobiac L, Kandiah M. Relationship between Quality of Life and Nutritional Status in Colorectal Cancer Patients Undergoing Chemotherapy. Malaysian Journal of Nutrition. 2017;23.
62.
go back to reference Zhang L, Wang S, Gao X, Gao T, Huang L, Lian B, et al. Poor Pre-operative Nutritional Status Is a Risk Factor of Post-operative Infections in Patients With Gastrointestinal Cancer—A Multicenter Prospective Cohort Study. Frontiers in Nutrition. 2022;9. Zhang L, Wang S, Gao X, Gao T, Huang L, Lian B, et al. Poor Pre-operative Nutritional Status Is a Risk Factor of Post-operative Infections in Patients With Gastrointestinal Cancer—A Multicenter Prospective Cohort Study. Frontiers in Nutrition. 2022;9.
63.
go back to reference Maurício SF, Da Silva JB, Bering T, Correia MITD. Relationship between nutritional status and the Glasgow Prognostic Score in patients with colorectal cancer. Nutrition. 2013;29:625–9.PubMedCrossRef Maurício SF, Da Silva JB, Bering T, Correia MITD. Relationship between nutritional status and the Glasgow Prognostic Score in patients with colorectal cancer. Nutrition. 2013;29:625–9.PubMedCrossRef
64.
go back to reference Ræder H, Henriksen C, Bøhn SK, O`de Fey Vilbo A-R, Henriksen HB, Kværner AS, et al. Agreement between PG-SGA category and fat-free mass in colorectal cancer patients. Clinical Nutrition ESPEN. 2018;27:24–31. Ræder H, Henriksen C, Bøhn SK, O`de Fey Vilbo A-R, Henriksen HB, Kværner AS, et al. Agreement between PG-SGA category and fat-free mass in colorectal cancer patients. Clinical Nutrition ESPEN. 2018;27:24–31.
65.
go back to reference Souza BUD, Souza NCS, Martucci RB, Rodrigues VD, Pinho NBD, Gonzalez MC, Avesani CM. Factors Associated with Sarcopenia in Patients with Colorectal Cancer. Nutr Cancer. 2018;70:176–83.PubMedCrossRef Souza BUD, Souza NCS, Martucci RB, Rodrigues VD, Pinho NBD, Gonzalez MC, Avesani CM. Factors Associated with Sarcopenia in Patients with Colorectal Cancer. Nutr Cancer. 2018;70:176–83.PubMedCrossRef
66.
go back to reference Velasco RN, Catedral LIG, Chua AV, Hernandez ARB, King REC, Leones LMB, et al. The Impact of Malnutrition on the Quality of Life of Colorectal Cancer Patients in a Tertiary Hospital. Nutr Cancer. 2022;74:2937–45.PubMedCrossRef Velasco RN, Catedral LIG, Chua AV, Hernandez ARB, King REC, Leones LMB, et al. The Impact of Malnutrition on the Quality of Life of Colorectal Cancer Patients in a Tertiary Hospital. Nutr Cancer. 2022;74:2937–45.PubMedCrossRef
67.
go back to reference Xu H, Kong F. Malnutrition-Related Factors Increased the Risk of Anastomotic Leak for Rectal Cancer Patients Undergoing Surgery. Biomed Res Int. 2020;2020:5059670.PubMedPubMedCentralCrossRef Xu H, Kong F. Malnutrition-Related Factors Increased the Risk of Anastomotic Leak for Rectal Cancer Patients Undergoing Surgery. Biomed Res Int. 2020;2020:5059670.PubMedPubMedCentralCrossRef
68.
go back to reference Vandebroek AJ, Schrijvers D. Nutritional issues in anti-cancer treatment. Ann Oncol. 2008;19(Suppl 5):v52–5.PubMedCrossRef Vandebroek AJ, Schrijvers D. Nutritional issues in anti-cancer treatment. Ann Oncol. 2008;19(Suppl 5):v52–5.PubMedCrossRef
69.
go back to reference Gupta A, Gupta E, Hilsden R, Hawel JD, Elnahas AI, Schlachta CM, Alkhamesi NA. Preoperative malnutrition in patients with colorectal cancer. Can J Surg. 2021;64:E621–9.PubMedPubMedCentralCrossRef Gupta A, Gupta E, Hilsden R, Hawel JD, Elnahas AI, Schlachta CM, Alkhamesi NA. Preoperative malnutrition in patients with colorectal cancer. Can J Surg. 2021;64:E621–9.PubMedPubMedCentralCrossRef
70.
go back to reference Antonella D, Rosa D, Ines A, Addolorata C, Vito Michele G, Eufemia S, et al. Assessment of Nutritional and Inflammatory Status to Determine the Prevalence of Malnutrition in Patients Undergoing Surgery for Colorectal Carcinoma. Anticancer Res. 2017;37:1281.CrossRef Antonella D, Rosa D, Ines A, Addolorata C, Vito Michele G, Eufemia S, et al. Assessment of Nutritional and Inflammatory Status to Determine the Prevalence of Malnutrition in Patients Undergoing Surgery for Colorectal Carcinoma. Anticancer Res. 2017;37:1281.CrossRef
71.
go back to reference Barreiro Domínguez E, Sánchez Santos R, Ballinas Miranda JR, Carrera Dacosta E, Pérez Corbal L, Diz Jueguen S, Mallo FF. Prognostic factors for malnutrition in patients with colorectal cancer. Nutr Hosp. 2022;39:1306–15.PubMed Barreiro Domínguez E, Sánchez Santos R, Ballinas Miranda JR, Carrera Dacosta E, Pérez Corbal L, Diz Jueguen S, Mallo FF. Prognostic factors for malnutrition in patients with colorectal cancer. Nutr Hosp. 2022;39:1306–15.PubMed
72.
go back to reference Rasschaert M, Vandecandelaere P, Marechal S, D’hondt R, Vulsteke C, Mailleux M, et al. Malnutrition prevalence in cancer patients in Belgium: The ONCOCARE study. Supportive Care in Cancer. 2024;32. Rasschaert M, Vandecandelaere P, Marechal S, D’hondt R, Vulsteke C, Mailleux M, et al. Malnutrition prevalence in cancer patients in Belgium: The ONCOCARE study. Supportive Care in Cancer. 2024;32.
73.
go back to reference Winichagoon P, Margetts BM. The double burden of malnutrition in low-and middle-income countries. Energy Balance and Obesity. 2017. Winichagoon P, Margetts BM. The double burden of malnutrition in low-and middle-income countries. Energy Balance and Obesity. 2017.
74.
go back to reference Fatiregun OA, Bakewell N. Malnutrition after cancer surgery in low-income and middle-income countries. Lancet Glob Health. 2023;11:e302–3.PubMedCrossRef Fatiregun OA, Bakewell N. Malnutrition after cancer surgery in low-income and middle-income countries. Lancet Glob Health. 2023;11:e302–3.PubMedCrossRef
75.
go back to reference Abancens M, Bustos V, Harvey H, McBryan J, Harvey BJ. Sexual Dimorphism in Colon Cancer. Front Oncol. 2020;10:1–10.CrossRef Abancens M, Bustos V, Harvey H, McBryan J, Harvey BJ. Sexual Dimorphism in Colon Cancer. Front Oncol. 2020;10:1–10.CrossRef
76.
go back to reference Gao R-N, Neutel CI, Wai E. Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health. 2008;30:194–201.CrossRef Gao R-N, Neutel CI, Wai E. Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health. 2008;30:194–201.CrossRef
77.
go back to reference Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, et al. Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany. PLoS ONE. 2013;8: e68077.PubMedPubMedCentralCrossRef Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, et al. Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany. PLoS ONE. 2013;8: e68077.PubMedPubMedCentralCrossRef
78.
go back to reference Kamińska J, Koper-Lenkiewicz OM, Ponikwicka-Tyszko D, Lebiedzińska W, Palak E, Sztachelska M, et al. New Insights on the Progesterone (P4) and PGRMC1/NENF Complex Interactions in Colorectal Cancer Progression. Cancers (Basel). 2023;15. Kamińska J, Koper-Lenkiewicz OM, Ponikwicka-Tyszko D, Lebiedzińska W, Palak E, Sztachelska M, et al. New Insights on the Progesterone (P4) and PGRMC1/NENF Complex Interactions in Colorectal Cancer Progression. Cancers (Basel). 2023;15.
80.
go back to reference Sasso CV, Santiano FE, Campo Verde Arboccó F, Zyla LE, Semino SN, Guerrero-Gimenez ME, et al. Estradiol and progesterone regulate proliferation and apoptosis in colon cancer. Endocrine Connections. 2019;8:217–29. Sasso CV, Santiano FE, Campo Verde Arboccó F, Zyla LE, Semino SN, Guerrero-Gimenez ME, et al. Estradiol and progesterone regulate proliferation and apoptosis in colon cancer. Endocrine Connections. 2019;8:217–29.
81.
go back to reference Lee D-W, Han S-W, Cha Y, Rhee YY, Bae JM, Cho N-Y, et al. Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX. Clin Epigenetics. 2015;7:63.PubMedPubMedCentralCrossRef Lee D-W, Han S-W, Cha Y, Rhee YY, Bae JM, Cho N-Y, et al. Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX. Clin Epigenetics. 2015;7:63.PubMedPubMedCentralCrossRef
82.
go back to reference Nazemalhosseini Mojarad E, Kuppen PJ, Aghdaei HA, Zali MR. The CpG island methylator phenotype (CIMP) in colorectal cancer. Gastroenterol Hepatol Bed Bench. 2013;6:120–8.PubMed Nazemalhosseini Mojarad E, Kuppen PJ, Aghdaei HA, Zali MR. The CpG island methylator phenotype (CIMP) in colorectal cancer. Gastroenterol Hepatol Bed Bench. 2013;6:120–8.PubMed
83.
go back to reference Rydbeck D, Asplund D, Bock D, Haglind E, Park J, Rosenberg J, et al. Younger age at onset of colorectal cancer is associated with increased patient’s delay. Eur J Cancer. 2021;154:269–76.PubMedCrossRef Rydbeck D, Asplund D, Bock D, Haglind E, Park J, Rosenberg J, et al. Younger age at onset of colorectal cancer is associated with increased patient’s delay. Eur J Cancer. 2021;154:269–76.PubMedCrossRef
84.
go back to reference Amitay EL, Carr PR, Jansen L, Roth W, Alwers E, Herpel E, et al. Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways. Br J Cancer. 2020;122:1604–10.PubMedPubMedCentralCrossRef Amitay EL, Carr PR, Jansen L, Roth W, Alwers E, Herpel E, et al. Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways. Br J Cancer. 2020;122:1604–10.PubMedPubMedCentralCrossRef
85.
go back to reference Cho S, Shin A, Park SK, Shin HR, Chang SH, Yoo KY. Alcohol Drinking, Cigarette Smoking and Risk of Colorectal Cancer in the Korean Multi-center Cancer Cohort. J Cancer Prev. 2015;20:147–52.PubMedPubMedCentralCrossRef Cho S, Shin A, Park SK, Shin HR, Chang SH, Yoo KY. Alcohol Drinking, Cigarette Smoking and Risk of Colorectal Cancer in the Korean Multi-center Cancer Cohort. J Cancer Prev. 2015;20:147–52.PubMedPubMedCentralCrossRef
86.
go back to reference Songtanin B, Chu VM, Deb A, Islam S, Islam E, Nugent K. Vomiting and profound weight loss as a clue to the diagnosis of malignant coloduodenal fistula. Proc (Bayl Univ Med Cent). 2022;35:237–8.PubMed Songtanin B, Chu VM, Deb A, Islam S, Islam E, Nugent K. Vomiting and profound weight loss as a clue to the diagnosis of malignant coloduodenal fistula. Proc (Bayl Univ Med Cent). 2022;35:237–8.PubMed
87.
go back to reference Hariyanto TI, Kurniawan A. Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment. Cancer Treatment and Research Communications. 2021;27: 100336.PubMedCrossRef Hariyanto TI, Kurniawan A. Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment. Cancer Treatment and Research Communications. 2021;27: 100336.PubMedCrossRef
88.
go back to reference Tuomisto AE, Mäkinen MJ, Väyrynen JP. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019;25:4383–404.PubMedPubMedCentralCrossRef Tuomisto AE, Mäkinen MJ, Väyrynen JP. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019;25:4383–404.PubMedPubMedCentralCrossRef
89.
go back to reference Rasic I, Radovic S, Aksamija G. Relationship Between Chronic Inflammation and the Stage and Histopathological Size of Colorectal Carcinoma. Med Arch. 2016;70:104–7.PubMedPubMedCentralCrossRef Rasic I, Radovic S, Aksamija G. Relationship Between Chronic Inflammation and the Stage and Histopathological Size of Colorectal Carcinoma. Med Arch. 2016;70:104–7.PubMedPubMedCentralCrossRef
91.
go back to reference Zhang M, Yang J, Jiang H, Jiang H, Wang Z. Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients. BMC Cancer. 2021;21:258.PubMedPubMedCentralCrossRef Zhang M, Yang J, Jiang H, Jiang H, Wang Z. Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients. BMC Cancer. 2021;21:258.PubMedPubMedCentralCrossRef
92.
go back to reference Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, et al. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases. 2023;10:1367–401.CrossRef Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, et al. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases. 2023;10:1367–401.CrossRef
93.
go back to reference Nolden A, Joseph PV, Kober KM, Cooper BA, Paul SM, Hammer MJ, et al. Co-occurring Gastrointestinal Symptoms Are Associated With Taste Changes in Oncology Patients Receiving Chemotherapy. J Pain Symptom Manage. 2019;58:756–65.PubMedPubMedCentralCrossRef Nolden A, Joseph PV, Kober KM, Cooper BA, Paul SM, Hammer MJ, et al. Co-occurring Gastrointestinal Symptoms Are Associated With Taste Changes in Oncology Patients Receiving Chemotherapy. J Pain Symptom Manage. 2019;58:756–65.PubMedPubMedCentralCrossRef
95.
go back to reference Lovey J, Molnar A, Banky B. Long-term nutrition in patients candidate to neoadjuvant and adjuvant treatments. Eur J Surg Oncol. 2023. Lovey J, Molnar A, Banky B. Long-term nutrition in patients candidate to neoadjuvant and adjuvant treatments. Eur J Surg Oncol. 2023.
96.
go back to reference Ihara K, Yamaguchi S, Shida Y, Fujita J, Matsudera S, Kikuchi M, et al. Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer. Journal of the Anus, Rectum and Colon. 2019;3:78–83.PubMedPubMedCentralCrossRef Ihara K, Yamaguchi S, Shida Y, Fujita J, Matsudera S, Kikuchi M, et al. Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer. Journal of the Anus, Rectum and Colon. 2019;3:78–83.PubMedPubMedCentralCrossRef
97.
go back to reference Sud S, O’Callaghan C, Jonker C, Karapetis C, Price T, Tebbutt N, et al. Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response. Curr Oncol. 2018;25:e516–26.PubMedPubMedCentralCrossRef Sud S, O’Callaghan C, Jonker C, Karapetis C, Price T, Tebbutt N, et al. Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response. Curr Oncol. 2018;25:e516–26.PubMedPubMedCentralCrossRef
98.
go back to reference Bettge K, Kahle M, Abd El Aziz MS, Meier JJ, Nauck MA. Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials. Diabetes Obes Metab. 2017;19:336–47. Bettge K, Kahle M, Abd El Aziz MS, Meier JJ, Nauck MA. Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials. Diabetes Obes Metab. 2017;19:336–47.
99.
go back to reference Hall C, Choi H. Chapter 15 - Side effects of antihypertensive drugs. In: Ray SD, editor. Side Effects of Drugs Annual. 45: Elsevier; 2023. p. 199–208. Hall C, Choi H. Chapter 15 - Side effects of antihypertensive drugs. In: Ray SD, editor. Side Effects of Drugs Annual. 45: Elsevier; 2023. p. 199–208.
100.
go back to reference Dev R, Bruera E, Dalal S. Insulin resistance and body composition in cancer patients. Annals of Oncology. 2018;29:ii18-ii26. Dev R, Bruera E, Dalal S. Insulin resistance and body composition in cancer patients. Annals of Oncology. 2018;29:ii18-ii26.
101.
go back to reference Rajamanickam A, Munisankar S, Dolla CK, Thiruvengadam K, Babu S. Impact of malnutrition on systemic immune and metabolic profiles in type 2 diabetes. BMC Endocr Disord. 2020;20:168.PubMedPubMedCentralCrossRef Rajamanickam A, Munisankar S, Dolla CK, Thiruvengadam K, Babu S. Impact of malnutrition on systemic immune and metabolic profiles in type 2 diabetes. BMC Endocr Disord. 2020;20:168.PubMedPubMedCentralCrossRef
Metadata
Title
Global prevalence and moderating factors of malnutrition in colorectal cancer survivors: A meta-analysis
Authors
Hidayat Arifin
Yu-Hao Chu
Ruey Chen
Chiu-Kuei Lee
Doresses Liu
Christina Yeni Kustanti
Tintin Sukartini
Kondwani Joseph Banda
Kuei-Ru Chou
Publication date
29-01-2025
Publisher
Springer US
Published in
Journal of Cancer Survivorship
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-025-01747-y

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

Read more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now